title: [Metabolic emergencies in oncology: hypercalcemia. I. Pathogenesis].
abstract: The acute metabolic abnormalities associated with cancer may cause symptoms that require urgent medical treatment and may constitute a more dangerous threat to life than the cancer itself. Hypercalcaemia is probably the most common metabolic complication of neoplastic disease (occurring in up to 30% of cancer patients) and its timely treatment may often save the patient and may permit subsequent chemotherapy. In this communication we focused our attention on the pathogenetic mechanism (part 1), diagnosis and subsequent treatment of this metabolic disorder (part 2).
authors: Dipartimento di Medicina Sperimentale, Oncologia Medica, Università degli Studi de L'Aquila.
authors: C
authors: C
authors: Ficorella
authors: S
authors: S
authors: Tomao
authors: P
authors: P
authors: Cagnazzo
authors: N
authors: N
authors: Samà
authors: N
authors: N
authors: Mazzei
authors: P
authors: P
authors: Marchetti
mesh_terms: D001859:Bone Neoplasms / Q000150:complications / Q000556:secondary; D004630:Emergencies; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology*; D009369:Neoplasms / Q000150:complications / Q000378:metabolism*; D010281:Parathyroid Hormone / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism; D015291:Transforming Growth Factors / Q000378:metabolism
chemical_list: D010281:Parathyroid Hormone; D011453:Prostaglandins; D015291:Transforming Growth Factors
vernacular_title: Emergenze metaboliche in oncologia: l'ipercalcemia. Parte I. Patogenesi.